Journal article 838 views
Mammographic dysplasia as entry criterion for breast cancer prevention trials
The Lancet, Volume: 337, Issue: 8751, Start page: 1225
Swansea University Author:
Damon Berridge
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/0140-6736(91)92897-b
Abstract
Mammographic dysplasia as entry criterion for breast cancer prevention trials
| Published in: | The Lancet |
|---|---|
| ISSN: | 01406736 |
| Published: |
Elsevier BV
1991
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa27678 |
| first_indexed |
2016-05-04T01:33:19Z |
|---|---|
| last_indexed |
2018-02-09T05:11:02Z |
| id |
cronfa27678 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2016-05-03T15:55:58.7141449</datestamp><bib-version>v2</bib-version><id>27678</id><entry>2016-05-03</entry><title>Mammographic dysplasia as entry criterion for breast cancer prevention trials</title><swanseaauthors><author><sid>a3def496492ff026f3228f50fbf89525</sid><ORCID>0000-0002-5442-6686</ORCID><firstname>Damon</firstname><surname>Berridge</surname><name>Damon Berridge</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2016-05-03</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>The Lancet</journal><volume>337</volume><journalNumber>8751</journalNumber><paginationStart>1225</paginationStart><publisher>Elsevier BV</publisher><issnPrint>01406736</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>5</publishedMonth><publishedYear>1991</publishedYear><publishedDate>1991-05-31</publishedDate><doi>10.1016/0140-6736(91)92897-b</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-05-03T15:55:58.7141449</lastEdited><Created>2016-05-03T14:20:06.8466649</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Jack</firstname><surname>Cuzick</surname><order>1</order></author><author><firstname>Damon</firstname><surname>Berridge</surname><orcid>0000-0002-5442-6686</orcid><order>2</order></author><author><firstname>John</firstname><surname>Whitehead</surname><order>3</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2016-05-03T15:55:58.7141449 v2 27678 2016-05-03 Mammographic dysplasia as entry criterion for breast cancer prevention trials a3def496492ff026f3228f50fbf89525 0000-0002-5442-6686 Damon Berridge Damon Berridge true false 2016-05-03 MEDS Journal Article The Lancet 337 8751 1225 Elsevier BV 01406736 31 5 1991 1991-05-31 10.1016/0140-6736(91)92897-b COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2016-05-03T15:55:58.7141449 2016-05-03T14:20:06.8466649 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Jack Cuzick 1 Damon Berridge 0000-0002-5442-6686 2 John Whitehead 3 |
| title |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| spellingShingle |
Mammographic dysplasia as entry criterion for breast cancer prevention trials Damon Berridge |
| title_short |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| title_full |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| title_fullStr |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| title_full_unstemmed |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| title_sort |
Mammographic dysplasia as entry criterion for breast cancer prevention trials |
| author_id_str_mv |
a3def496492ff026f3228f50fbf89525 |
| author_id_fullname_str_mv |
a3def496492ff026f3228f50fbf89525_***_Damon Berridge |
| author |
Damon Berridge |
| author2 |
Jack Cuzick Damon Berridge John Whitehead |
| format |
Journal article |
| container_title |
The Lancet |
| container_volume |
337 |
| container_issue |
8751 |
| container_start_page |
1225 |
| publishDate |
1991 |
| institution |
Swansea University |
| issn |
01406736 |
| doi_str_mv |
10.1016/0140-6736(91)92897-b |
| publisher |
Elsevier BV |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
1991-05-31T04:17:41Z |
| _version_ |
1850731042329067520 |
| score |
11.08895 |

